CausalSentinel

Protein Dossier — IL15RA (Interleukin-15 receptor subunit alpha)

MR feasibility tier: A — Published pQTL-MR estimates exist for this protein (retrieved below - not computed here).

1. Published MR estimates (retrieved, not computed)

Outcome beta se p method nSNP cis/trans coloc
Non-cancer illness code self-reported: hypothyroidism or myxoedema 0.0697 0.0208 8.16e-04 Wald ratio 1 cis NA
Height 0.0181 0.00609 0.003 Wald ratio 1 cis NA
Sleep duration 0.00968 0.00392 0.0135 Wald ratio 1 cis NA
Diagnoses - main ICD10: K80 Cholelithiasis 0.0774 0.0324 0.0168 Wald ratio 1 cis NA
Body mass index (BMI) 0.0116 0.00502 0.0205 Wald ratio 1 cis NA
Weight 0.00991 0.00443 0.0254 Wald ratio 1 cis NA
Thalamus volume 28.7 13 0.027 Wald ratio 1 cis NA
Alzheimer’s disease 0.0717 0.0334 0.0318 Wald ratio 1 cis NA
Alcohol intake frequency -0.0159 0.00742 0.0326 Wald ratio 1 cis NA
Diagnoses - main ICD10: I80 Phlebitis and thrombophlebitis 0.137 0.0644 0.0333 Wald ratio 1 cis NA
Rheumatoid arthritis -0.0581 0.0292 0.0468 Wald ratio 1 cis NA
Mean cell volume -0.108 0.0546 0.0479 Wald ratio 1 cis NA
…and 91 more outcomes (see JSON)              

2. pQTL instrument availability (Tier-B probe)

Dataset Trait Author Year
prot-c-3445_53_2 IL-15 Ra Suhre K 2019

3. GWAS Catalog results — traits with signal at this locus

115 association rows across 60 traits (104 genome-wide significant rows). Associations are loci, not causal claims; the mapped gene at a locus is not necessarily the effector gene.

Trait best p lead SNP n assoc study MR status
IL2RA/NCR1 protein level ratio 7e-902 rs7911500 1 GCST90315161 no MR -> candidate analysis
Circulating IL15RA levels 2e-543 rs2228059 9 GCST90859870 no MR -> candidate analysis
IL15RA protein levels 8e-276 rs3136630 9 GCST90469555 no MR -> candidate analysis
Interleukin-15 receptor subunit alpha levels 2e-184 rs2228059 8 GCST90274800 no MR -> candidate analysis
Soluble interleukin-2 receptor subunit alpha 1e-100 rs7911500 2 GCST003088 no MR -> candidate analysis
Interleukin-15 receptor subunit alpha levels (IL15RA.14054.1 2e-91 rs8177641 4 GCST90241594 no MR -> candidate analysis
IL2RA protein levels 7e-73 rs146712466 7 GCST90469585 no MR -> candidate analysis
Circulating IL2RA levels 4e-66 rs183050850 2 GCST90859919 no MR -> candidate analysis
Serum levels of protein IL15RA 1e-63 rs7086174 5 GCST90087746 no MR -> candidate analysis
Interleukin-15 receptor subunit alpha (analyte X14054.17) le 3e-61 rs7086174 1 GCST90422434 no MR -> candidate analysis
Circulating NCR1 levels (id: OID01007_OID20566) 1e-44 rs8177653 3 GCST90860233 no MR -> candidate analysis
Circulating NCR1 levels (id: OID00816_OID20566) 1e-43 rs8177653 3 GCST90860146 no MR -> candidate analysis
…and 48 more traits (see JSON)          

4. Phenome map — where this gene is a genetic locus, vs. where MR exists

Top diseases by Open Targets association (of 312 total). Associations are loci, not causal claims. The causal-status column is a four-state triage per pair: established (curated) = a curated clinical assertion exists (ClinGen/G2P/GEL/Orphanet/ClinVar — any validity level, MR adds little); exploratory rare-variant signal = ExWAS burden evidence without curation — a candidate NEW gene-disease relationship; common-variant locus = GWAS signal, classic pQTL-MR territory; multi-layer = burden+GWAS together, an allelic-series candidate (the strongest causal setup). Burden estimand is carrier-vs-noncarrier, not per-SD MR.

Disease genetic assoc. burden (ExWAS) causal status MR status
neuroblastoma 0.55 common-variant locus no MR -> candidate analysis
alcohol drinking 0.463 common-variant locus no MR -> candidate analysis
arthropathy 0.457 common-variant locus no MR -> candidate analysis
atopic eczema 0.123 common-variant locus no MR -> candidate analysis
rheumatoid arthritis 0.031 common-variant locus MR: beta=-0.0581, p=0.0468 (cis)
Iron deficiency anemia 0.111 common-variant locus no MR -> candidate analysis

Of the 6 rows above, 5 have no MR estimate in this resource. Across all retrieved diseases for this gene: 0 exploratory rare-variant signal(s), 0 multi-layer (allelic-series candidate) pair(s). Final triage still belongs to a statistical geneticist.

5. Downstream annotation (druggability & safety preview)

Layer Result
ChEMBL druggability 0 known modulators (IL15-IL15 receptor)
gnomAD constraint pLI=4.5e-10, LOEUF=1.49 — LoF-tolerant
GWAS Catalog 160 unique SNPs / 403 rows
ClinVar 99 records; 1 pathogenic in sample of 30
PharmGKB/ClinPGx no annotations

Caveats declared by the tools

Sources

Provenance